#420 Recap Extravaganza: 2023 Highlights and Top Stories
Dec 25, 2023, 08:00 AM
Join us as we recap various topics discussed throughout the year, including hormonal and non-hormonal therapy for menopause symptoms, hemochromatosis, evaluation and management of hematuria, updates in diabetes management (insulin, GLP1 agonists, SGLT2 inhibitors, hypoglycemia), xylazine overdose and withdrawal, primary aldosteronism, resistant hypertension, delirium, and its implications, the ACORN trial on AKI risk with pip-tazo vs. cefepime, the REPRIEVE trial on statin therapy in patients with HIV, inpatient heart failure management, the implications of kratom use, and the effectiveness of RSV vaccines. Plus, Paul Williams (@PaulNWilliamz), Rahul Ganatra (@rbganatra), Nora Taranto (@norataranto), and Matt Watto (@doctorwatto) share their picks of the year and take a moment to reflect on their gratitude for the fans and the opportunity to work on Curbsiders.
Our team needed a break so we did not make CME for this episode.
Show Segments
Time Stamps are for Patreon (Ad-Free) Version
Our team needed a break so we did not make CME for this episode.
Show Segments
Time Stamps are for Patreon (Ad-Free) Version
- 00:00 Introduction and Overview
- 09:42 Hormonal and Non-Hormonal Therapy for Menopause Symptoms
- 14:20 Understanding Hemochromatosis
- 19:24 Evaluation and Management of Hematuria
- 25:00 Updates in Diabetes Management
- 29:35 Xylazine Overdose and Withdrawal
- 35:35 Primary Aldosteronism
- 39:36 Resistant Hypertension
- 44:12 Delirium and its Implications
- 46:29 The Acorn trial and AKI risk
- 49:47 HIV trial: Reprieve
- 51:11 Updates in hospital medicine
- 56:00 Kratom and its implications
- 59:11 RSV vaccines and their effectiveness
- 01:05:38 Reflections and Gratitude
Credits
- Written, Produced, and Hosted by: Nora Taranto MD, Rahul Ganatra MD, MPH; Matthew Watto MD, FACP; Paul Williams MD, FACP
- Cover Art: Matthew Watto MD, FACP
- Showrunners: Matthew Watto MD, FACP; Paul Williams MD, FACP
- Technical Production: PodPaste
Transcript Disclaimer
We've included a a free AI-generated transcript which has not been corrected by a human for accuracy or completeness. Please consider this a starting point for further research and consultation. We disclaim any liability for damages or losses resulting from this content.
Sponsor - Glass Health
Glass Health was founded in 2021 and has the mission of empowering doctors with AI-powered clinical decision support.
Glass helps clinicians to draft differential diagnoses and draft clinical plans using physician-validated context.
You can also use Glass to capture knowledge of all the schemas, scripts, cases, and pearls that you encounter and leverage them to take better care of patients.
Try Glass for yourself by visiting https://glass.health Personal knowledge management features are completely free and with Glass Pro, you get access to their powerful AI.
You can get one month of Glass Pro free by signing up at https://glass.health and using the code CURBSIDERS
Glass, like a clinical reference text or podcast, should never replace clinician judgment.
We've included a a free AI-generated transcript which has not been corrected by a human for accuracy or completeness. Please consider this a starting point for further research and consultation. We disclaim any liability for damages or losses resulting from this content.
Sponsor - Glass Health
Glass Health was founded in 2021 and has the mission of empowering doctors with AI-powered clinical decision support.
Glass helps clinicians to draft differential diagnoses and draft clinical plans using physician-validated context.
You can also use Glass to capture knowledge of all the schemas, scripts, cases, and pearls that you encounter and leverage them to take better care of patients.
Try Glass for yourself by visiting https://glass.health Personal knowledge management features are completely free and with Glass Pro, you get access to their powerful AI.
You can get one month of Glass Pro free by signing up at https://glass.health and using the code CURBSIDERS
Glass, like a clinical reference text or podcast, should never replace clinician judgment.